Shaw RH, Tanner R, Djeddour D & Cortat G (2011). Classical biological control of Fallopia japonica in the United Kingdom – lessons for Europe. Weed Research51, 552–558.
Summary
The programme for the biological control of Fallopia japonica in the United Kingdom has provided some valuable insights into the practicalities of delivering a classical biological control programme against a weed in the European Union. In the absence of tailored legislation, the licensing process was complex but not prohibitive. It involved the production of a pest risk analysis (PRA; based on the EPPO template), an application through national legislation (the UK Wildlife and Countryside Act), the production of peer‐reviewed publications, expert committee consideration, further commissioned peer review and public consultations prior to final Ministerial judgement, which was granted in March 2010. Although there is room for some streamlining in the process, this approach has proved to be effective and robust and should be applicable to similar programmes in Europe. This is important, because classical biological control has considerable potential for the management of F. japonica and other weed targets throughout Europe, especially those impacting habitats where chemical use is all but impossible. The lessons learned from the knotweed biocontrol programme are discussed, and current weed biocontrol activities in Europe are briefly summarised. A classical biocontrol programme needs to deliver more than just pure science, because effective communication and negotiations in the public and political arena can provide more challenges than the traditional scientific ones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.